(Q73235232)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Recent Developments in the Epidemiology, Diagnosis, Treatment, and Prevention of Neurocysticercosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

White AC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Garcia HH

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

Current infectious disease reports

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

434-440

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

A Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18 kDa antigens

2 November 2019

cites work

1 reference

12 December 2020

Etiological spectrum of symptomatic localization related epilepsies: a study from South India.

1 reference

12 December 2020

Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures.

1 reference

12 December 2020

Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study.

1 reference

12 December 2020

Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities.

1 reference

12 December 2020

Single-day praziquantel therapy for neurocysticercosis

1 reference

12 December 2020

Neurocysticercosis: focus on intraventricular disease

1 reference

12 December 2020

Neurocysticercosis in persons with epilepsy in Medellín, Colombia. The Neuroepidemiological Research Group of Antioquia

1 reference

12 December 2020

Neurocysticercosis in children. Clinical experience in 122 patients

1 reference

12 December 2020

Prevalence of cysticercosis in epileptics and members of their families in Burundi

1 reference

12 December 2020

An endoscopic approach to cysticercosis cysts of the posterior third ventricle

1 reference

12 December 2020

Headache and cysticercosis in Ecuador, South America.

1 reference

12 December 2020

Update: the new ventriculoperitoneal shunt at The Institute of Neurology of Mexico

1 reference

12 December 2020

Parenchymal neurocysticercosis: follow-up and staging by MRI

1 reference

12 December 2020

Pharmacokinetic optimisation of the treatment of neurocysticercosis

1 reference

12 December 2020

Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs

1 reference

12 December 2020

Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2.

1 reference

12 December 2020

Cysticercosis. Clinical classification based on imaging studies

1 reference

12 December 2020

Taenia solium cysticercosis: host-parasite interactions and the immune response

1 reference

12 December 2020

A new shunt for hydrocephalus that relies on CSF production rather than on ventricular pressure: initial clinical experiences.

1 reference

12 December 2020

Development of a serologic assay to detect Taenia solium taeniasis

1 reference

12 December 2020

Is the course of neurocysticercosis modified by treatment with antihelminthic agents?

1 reference

12 December 2020

Endoscopic removal of a third ventricular cysticercal cyst.

1 reference

12 December 2020

Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil

1 reference

12 December 2020

Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients

1 reference

12 December 2020

Cysticercosis and epilepsy: a critical review.

1 reference

12 December 2020

Neurocysticercosis in Ceará State, northeastern Brazil: a review of 119 cases.

1 reference

12 December 2020

A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru

1 reference

12 December 2020

Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico.

1 reference

12 December 2020

Application of the enzyme-linked immunoelectrotransfer blot to filter paper blood spots to estimate seroprevalence of cysticercosis in Bolivia

1 reference

12 December 2020

Controversies in the management of cysticercosis

1 reference

12 December 2020

1 reference

12 December 2020

Spinal intramedullary cysticercosis

1 reference

12 December 2020

Neurocysticercosis: a major aetiological factor of late-onset epilepsy in Madagascar

1 reference

12 December 2020

Neurocysticercosis: a major cause of neurological disease worldwide

1 reference

12 December 2020

Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.

1 reference

12 December 2020

Single-day praziquantel versus 1-week albendazole for neurocysticercosis.

1 reference

12 December 2020

Persistent MR contrast enhancement of calcified neurocysticercosis lesions.

1 reference

12 December 2020

Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis

1 reference

12 December 2020

Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum.

1 reference

12 December 2020

Intramedullary spinal cysticercosis: response to albendazole: case reports and review of literature

1 reference

12 December 2020

Magnetisation transfer magnetic resonance imaging demonstration of perilesional gliosis--relation with epilepsy in treated or healed neurocysticercosis.

1 reference

12 December 2020

Reactivation of neurocysticercosis: case report.

1 reference

12 December 2020

Frequency of cerebral arteritis in subarachnoid cysticercosis: an angiographic study

1 reference

12 December 2020

High-dose praziquantel with cimetidine for refractory neurocysticercosis: a case report with clinical and MRI follow-up.

1 reference

12 December 2020

Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial

1 reference

12 December 2020

Treatment of porcine cysticercosis with oxfendazole: a dose-response trial.

1 reference

12 December 2020

Anterior cerebral artery territory infarction in neurocysticercosis: evaluation by MR angiography and in vivo proton MR spectroscopy

1 reference

12 December 2020

Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.

1 reference

12 December 2020

WITHDRAWN: Drugs for treating neurocysticercosis (tapeworm infection of the brain).

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD000215.PUB2

Identifiers

DOI

10.1007/S11908-999-0055-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095820%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference